A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Latest action. Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310) · May 14, 2026
Live record from Congress.gov. Plain-language summary and constitutional tags are pending editorial review.
Status
Introduced
May 14, 2026
In committee
May 14, 2026
Passed a chamber
Cleared Congress
Enacted
Plain-language explanation
Editor-written · not AI
A plain-language explanation for this bill is pending editorial review. By design these are written by editors and never auto-generated — read the official text through the sources above in the meantime.
Vote history
No recorded votes yet
This bill has not received a recorded floor vote in this dataset.
